UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure

Circulation (New York, N.Y.), 2000-02, Vol.101 (8), p.844-846

2000

Volltextzugriff (PDF)

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure

Circulation (New York, N.Y.), 1999-03, Vol.99 (8), p.990-992

1999

Volltextzugriff (PDF)

Heart failure with preserved ejection fraction: a systemic disorder?

La revue de medecine interne, 2012-07, Vol.33 (7), p.370-380

2012

Volltextzugriff (PDF)

Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction

European heart journal, 2007-11, Vol.28 (21), p.2667-2677

2007

Volltextzugriff (PDF)

Progression and management of chronic heart failure

Panminerva medica, 2007-09, Vol.49 (3), p.109

2007

Volltextzugriff (PDF)

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure

Circulation (New York, N.Y.), 1983-05, Vol.67 (5), p.1065-1070

1983

Volltextzugriff (PDF)

Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York heart failure registry

Journal of the American College of Cardiology, 2004-04, Vol.43 (8), p.1432-1438

2004

Volltextzugriff (PDF)

Impact of functional decline on outcome in elderly patients with acute coronary syndromes

American journal of critical care, 2013-01, Vol.22 (1), p.e1-e11

2013

Volltextzugriff (PDF)

Sarcoplasmic reticulum calcium transport and Ca(2+)-ATPase gene expression in thoracic and abdominal aortas of normotensive and spontaneously hypertensive rats

The Journal of biological chemistry, 1993-04, Vol.268 (11), p.8325-8331

1993

Volltextzugriff (PDF)

Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects

Journal of cardiac failure, 2001-09, Vol.7 (3), p.265-268

2001

Volltextzugriff (PDF)

Dose-Dependent Blockade of the Angiotensin II Type 1 Receptor with Losartan in Normal Volunteers

Journal of cardiovascular pharmacology, 2001-06, Vol.37 (6), p.692-696

2001

Volltextzugriff (PDF)

Therapeutic Update: Non-Selective Beta- and Alpha-Adrenergic Blockade in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure

Journal of the American College of Cardiology, 2004-08, Vol.44 (3), p.497-502

2004

Volltextzugriff (PDF)

Elevated Plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure

Circulation (New York, N.Y.), 2002-08, Vol.106 (9), p.1055-1057

2002

Volltextzugriff (PDF)

Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium

Journal of applied physiology (1985), 2002-03, Vol.92 (3), p.1331-1338

2002

Volltextzugriff (PDF)

Age-related changes in sarcoplasmic reticulum Ca(2+)-ATPase and alpha-smooth muscle actin gene expression in aortas of normotensive and spontaneously hypertensive rats

Circulation research, 1993-02, Vol.72 (2), p.341-348

1993

Volltextzugriff (PDF)

Effects of Acute Angiotensin Converting Enzyme Inhibition on Renal Blood Flow in Patients with Stable Congestive Heart Failure

The American journal of the medical sciences, 1986-09, Vol.292 (3), p.123-127

1986

Volltextzugriff (PDF)

Diabetes lowers aerobic capacity in heart failure

Journal of the American College of Cardiology, 2005-09, Vol.46 (5), p.930-931

2005

Volltextzugriff (PDF)

Long-Term Effects of Carvedilol or Metoprolol on Left Ventricular Function in Ischemic and Nonischemic Cardiomyopathy

The American journal of cardiology, 2005-05, Vol.95 (9), p.1114-1116

2005

Volltextzugriff (PDF)

Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying disease

Journal of the American College of Cardiology, 1983-08, Vol.2 (2), p.327-331

1983

Volltextzugriff (PDF)

Therapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure

Current cardiology reports, 2000-05, Vol.2 (3), p.258-262

2000

Volltextzugriff (PDF)

Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure

The American journal of cardiology, 2004-12, Vol.94 (12), p.1501-1505

2004

Volltextzugriff (PDF)

Peripheral circulatory response in cardiac failure

Hospital Practice, 1991-09, Vol.26 (9), p.75-82

1991

Volltextzugriff (PDF)

Heart failure treatment and renal function

The American heart journal, 2004-02, Vol.147 (2), p.193-194

2004

Volltextzugriff (PDF)

Management of heart failure

Current cardiology reports, 2000-05, Vol.2 (3), p.221-224

Le Jemtel, T H

2000

Volltextzugriff (PDF)

Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure

Journal of the renin-angiotensin-aldosterone system, 2000-06, Vol.1 (2), p.147-150

2000

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(134)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure

Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure

Heart failure with preserved ejection fraction: a systemic disorder?

Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction

Progression and management of chronic heart failure

Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure

Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: Results of the New York heart failure registry

Impact of functional decline on outcome in elderly patients with acute coronary syndromes

Sarcoplasmic reticulum calcium transport and Ca(2+)-ATPase gene expression in thoracic and abdominal aortas of normotensive and spontaneously hypertensive rats

Angiotensin II type 1 receptor blockade with 80 and 160 mg valsartan in healthy, normotensive subjects

Dose-Dependent Blockade of the Angiotensin II Type 1 Receptor with Losartan in Normal Volunteers

Therapeutic Update: Non-Selective Beta- and Alpha-Adrenergic Blockade in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure

Elevated Plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure

Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium

Age-related changes in sarcoplasmic reticulum Ca(2+)-ATPase and alpha-smooth muscle actin gene expression in aortas of normotensive and spontaneously hypertensive rats

Effects of Acute Angiotensin Converting Enzyme Inhibition on Renal Blood Flow in Patients with Stable Congestive Heart Failure

Diabetes lowers aerobic capacity in heart failure

Long-Term Effects of Carvedilol or Metoprolol on Left Ventricular Function in Ischemic and Nonischemic Cardiomyopathy

Long-term therapy with a new cardiotonic agent, WIN 47203: Drug-dependent improvement in cardiac performance and progression of the underlying disease

Therapeutic implications of escape from angiotensin-converting enzyme inhibition in patients with chronic heart failure

Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure

Peripheral circulatory response in cardiac failure

Heart failure treatment and renal function

Management of heart failure

Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure

Suchergebnisse filtern